Connection
Li-kheng Ngov to Glutamates
This is a "connection" page, showing publications Li-kheng Ngov has written about Glutamates.
|
|
Connection Strength |
|
 |
|
 |
|
0.025 |
|
|
|
-
Dowell JE, Dunphy FR, Taub RN, Gerber DE, Ngov L, Yan J, Xie Y, Kindler HL. A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesothelioma. Lung Cancer. 2012 Sep; 77(3):567-71.
Score: 0.025